Skip to content

Incidence of Urinary Tract Infection After Urodynamic Investigation

Incidence of Urinary Tract Infection and Germ Identification After Urodynamic Investigation in Patients With Spinal Cord Injury

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01297647
Enrollment
317
Registered
2011-02-17
Start date
2010-05-31
Completion date
2012-05-31
Last updated
2016-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic Bladder

Keywords

urinary tract infection, urodynamics, spinal cord injury

Brief summary

The purpose of this study is to evaluate the incidence of urinary tract infection after urodynamic investigation and to identify the involved germs.

Detailed description

Patients with neurogenic bladder dysfunction after spinal cord injury need lifelong urologic control examinations with CMG (urodynamic examination). The manipulation may cause urinary tract infections which have to be treated. Patients often noticed an infection after a CMG examination. Aim of this study is the determination of the infection rate and germs. Also should be noticed the pre-interventional infections and differences between the causing germs. Simultaneously the investigators test the reliability of the quicktest for urinary infection. Additionally the investigators will examine the Quality of Life in patients with neurogenic bladder dysfunction.

Interventions

Standard urodynamic investigation according to the ICS standard, Good urodynamic practice.Following insertion of 8 F transurethral catheter, retrograde filling of the bladder (20 mL/min) with body warm saline. Current recording of pabd. , pves and pdet., subsequently pressure flow study. Additionally imaging with fluoroscopy to detect possible vesico ureteral renal reflux.

Sponsors

Balgrist University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with neurogenic lower urinary tract dysfunction with scheduled urodynamic investigation * No antibiotic treatment * Written informed consent

Exclusion criteria

* Pregnancy and breastfeeding * Current antibiotic therapy

Design outcomes

Primary

MeasureTime frameDescription
Incidence of urinary tract infection following urodynamic investigation3 days after urodynamic investigationevery patient receives the urine examination before the urodynamic investigation and hospitalized patients additionally 3 days later and ambulatory patients in case of urinary tract infection

Secondary

MeasureTime frameDescription
Name and number of identified bacterial species30 minutes before examination
Number of hospitalized and number of ambulatory patients with infection of the lower urinary tract3 days after examination
Incidence of urinary tract infection before urodynamic investigation30 minutes before urodynamic investigationevery patient receives the urine examination before the urodynamic investigation to detect a potentially urinary tract infection

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026